Nanoparticle approaches for manipulating cytokine delivery and neutralization

Rui Wang1, Luke J Kubiatowicz1, Runhe Zhang1

  • 1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, San Diego, United States.

PubMed

Insights

Nanotechnology enhances cytokine therapies by improving delivery and neutralization. This review explores nanoparticle platforms for treating immune disorders, overcoming toxicity and pharmacokinetic challenges for better clinical outcomes.

Area of Science:

  • Immunology and Nanomedicine
  • Therapeutic applications of cytokines and nanoparticles

Background:

  • Cytokines are key regulators of immune responses, inflammation, and tolerance.
  • Cytokine-based therapies show promise for cancer, infections, and autoimmune diseases but face challenges like toxicity and poor pharmacokinetics.
  • Nanotechnology offers solutions to improve cytokine delivery and neutralization.

Purpose of the Study:

  • To review nanoparticle-based strategies for enhancing cytokine delivery and neutralization.
  • To highlight advancements in nanoparticle platforms for cytokine manipulation.
  • To discuss clinical developments and future challenges in nanoparticle-cytokine therapeutics.

Main Methods:

  • Review of nanoparticle systems for encapsulating protein, DNA, or mRNA payloads for cytokine delivery.
  • Analysis of nanoparticle platforms for cytokine neutralization, including antibody complexes and cell membrane coatings.
  • Examination of clinical progress and challenges in nanoparticle-mediated cytokine therapies.

Main Results:

  • Nanoparticle platforms can effectively encapsulate various payloads for targeted cytokine delivery.
  • Novel nanoparticle designs facilitate efficient cytokine neutralization, mitigating adverse effects.
  • Emerging clinical data show promise for nanoparticle-enhanced cytokine therapies.

Conclusions:

  • Nanoparticle-based approaches significantly improve cytokine delivery and neutralization, addressing key limitations of traditional therapies.
  • Further research and clinical development are crucial to fully harness the therapeutic potential of nanoparticle-cytokine strategies.
  • Overcoming remaining challenges will pave the way for advanced treatments for immune-related diseases.